Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of early postoperative cognitive impairment after pelvic or femoral orthopedic surgery
IRCT20140109016151N7Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-operative cognitive decline (POCD) comparing Dexmedetomidine with Placebo saline (2 arms). Primary endpoint: Postoperative cognitive impairment. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on IRCT20140109016151N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140109016151N7.